Phase Ii Study of Dabrafenib and Trametinib Following Progression on Braf Inhibitor Monotherapy in Metastatic Melanoma: Exploration of Clinical and Molecular Predictors of Response.Jennifer Leigh McQuade,Guo Chen,David J. Panka,Alexandre Reuben,Roland L. Bassett,Aron Joon,Alexander J. F. Lazar,Michael T. Tetzlaff,Lauren Simpson,Rosalind Mouton,Sapna Pradyuman Patel,Isabella Claudia Glitza,Wen-Jen Hwu,Rodabe Navroze Amaria,Adi Diab,Patrick Hwu,Jennifer Ann Wargo,Ryan J. Sullivan,Kevin Kim,Michael A. DaviesJOURNAL OF CLINICAL ONCOLOGY（2015）引用 1|浏览45暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
